Neudle.com: dystonia parkinsonism

Differential
(Click to cross reference)

aciduria

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome-related complex

adolescent medicine

advances in neurology

adverse drug reaction

agitation

akathisia

akinesia of eyelid function

alcohol

algorithm

alien hand syndrome

alternating hemiplegia

alternating hemiplegia of childhood

anti basal ganglia antibodies

anti IgLON5

anticholinergic drugs

aphasia

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

attention deficit disorder with hyperactivity

atypical

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autonomic dysfunction

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

bent spine syndrome

beta adrenergic blocker

calcification, intracranial

calcium antagonist

calcium antagonist, side effects of

calculations

camptocormia

carbamazepine

carbon monoxide poisoning

CAT scan

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, isodense lesion with acute hemorrhage

CAT scan, muscle

catecholamine

central hypoventilation

central nervous system, infection of

cerebral cortical atrophy

cerebral ischemia

cerebral palsy

cerebral vasculature, calcification

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular accident, complications with

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

comprehension, impaired

compression fracture

conjugate gaze, forced

consanguinity

contractures, joint

convergence, impaired

conversion reaction

copper metabolism, abnormal

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

crying, pathologic

cultured skin fibroblasts

cyanide poison

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diagnostic criteria

differential diagnosis

diplopia

disability, neurological

diurnal variation

dopa responsive dystonia

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, causes of

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, axial

dystonia, cervical

dystonia, children

dystonia, classification

dystonia, delayed onset

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, psychogenic

dystonia, treatment of

dystonic reaction, acute

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, viral

encephalopathy

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

equinovarus

exercise

exercise-induced neurologic dysfunction

extrapyramidal

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

Fahr disease

falling

familial

fine motor function, impaired

flunarizine

fluoxetine

foot deformity

frontal behavioral spatial syndrome

frontal lobe, atrophy

gait disorder

gait, apraxic

galactorrhea

gamma amino butyric acid

gangliosidosis GM1

gaze palsy

gaze palsy, supranuclear

genetic diagnosis, prenatal

genetic neurologic disorders

genetic testing

gests antagoniste

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

grasp reflex

grimacing

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination, visual

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatosplenomegaly

heralding manifestation

HLA

hoarseness

homovanillic acid

human immunodeficiency virus type 1

iatrogenic neurologic disorders

inborn errors of metabolism

inclusion bodies, intranuclear

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

jaw jerk, abnormal

Kayser-Fleischer ring

kyphosis

language disorder in adults

laughing, pathologic

L-dopa

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

Lewy body disease, diffuse

lipid storage disorder of CNS

manganese intoxication

masked facies

medical-legal aspects of neurology

memory, defect of recent

memory, impairment of

meningitis

meningitis, carcinomatous

mental status, abnormal

metabolic disorder, primary

mitochondrial disease

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI

MRI pattern

MRI, abnormal

MRI, CAT scan compared to

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, mouse ears

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis

multiple system atrophy

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurochemistry

neurodegeneration with brain iron accumulation

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal intranuclear inclusion disease

next-generation sequencing

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

norepinephrine

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

opened mouth

ophthalmoplegia

optic atrophy

optokinetic nystagmus, abnormal

paraplegia, in flexion

parasomnia

paraspinal muscle

paraspinal muscle weakness

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, juvenile

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, on-off phenomena in

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

paroxysmal nonkinesigenic dyskinesia

pathologic reflex

patient information and support

penguin silhouette sign

penicillamine

personality change

phenothiazine

phenothiazine, dyskinesia associated with

phenylketonuria

Pick's disease

pigmentary retinopathy

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

POLG1 gene

polycythemia, secondary

pons, lesion of

postural abnormality

precipitating factors

primary familial brain calcification

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

propranolol

pseudobulbar palsy

pseudohypoparathyroidism

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

putamen, lesion of, bilateral

quadriplegia

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading problem, causes of

recurrent

Red flags

reflex sympathetic dystrophy

release phenomena

renal failure

repetition, impaired

respirations in CNS disease

restless leg syndrome

reversible neurologic disorder

saccadic eye movements, abnormal

salivation, excessive

scoliosis

seizure

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss

sensory loss, cortical

sensory tricks

sequencing difficulty

short stature

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

somnolence

spastic dysphonia

speech disorder

speech disorder, childhood

stimulation, deep brain

stimulation, thalamic

stooped posture

striatal encephalitis

striopallidodentate calcifications, familial idiopathic

subarachnoid hemorrhage

substantia nigra

suck reflex

swallow evaluation

symmetric brain lesions

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, lesion of-bilateral

torticollis, post traumatic

toxoplasmosis, CNS

trauma

treatment failure

treatment of neurologic disorder

tremor, post traumatic

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness, progressive

X-linked dystonia-parkinsonism syndrome

Showing articles 600 to 650 of 1676 << Previous Next >>

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000

Structural Changes of the Substantia Nigra in Parkinson's Disease as Revealed by MR Imaging
AJNR 21:697-701, Hutchinson,M.&Raff,U., 2000

Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000

C1/C2 Rotary Subluxation Due to Spasmodic Torticollis
JNNP 69:135-136, Dalvie,S. et al, 2000

Surgery for Parkinson Disease
Arch Neurol 57:1118-1125, Lang,A.E., 2000

Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000

The Brain lesion Responsible for Parkinsonism After Carbon Monoxide Poisnoning
Arch Neurol 57:1214-1218, Sohn,Y.H. et al, 2000

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000

Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000

Effects of Bilateral Posteroventral Pallidotomy on Gait of Subjects with Parkinson Disease
Arch Neurol 57:198-204, Siegel,K.L.&Metman,L.V., 2000

Striatal Dopamine Trnasporter Binding Assessed by [I-123]IPT and Single Photon Emission Computed tomography in Patients with Early Parkinson's Disease, Implications for a Preclinical Diagnosis
Arch Neurol 57:205-208, Schwarz,J.,et al, 2000

The Nonmotor Problems of Parkinson's Disease
The Neurologist 6:18-27, Friedman,J.H.&Fernandez,H.H., 2000

Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000

Frequency of the DYT1 Mutation in Primary Torsion Dystonia Without Family History
ArchNeurol 57:333-335, Brassat,D.,et al, 2000

Language Disturbances in Corticobasal Degeneration
Neurol 54:990-992, Frattali,C.M.,et al, 2000

The Evolution of Diagnosis in Early Parkinson Disease
ArchNeurol 57:369-372, Jankovic,J.,et al, 2000

Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000

Botulinum Toxin A as Treatment for Drooling Saliva in PD
Neurol 54:244-247, Pal,P.K.,et al, 2000

Botulinum Toxin is a Useful Treatment in Excessive Drooling of Saliva
JNNP 67:697, Bhatia,K.P.,et al, 1999

Acute and Reversible Parkinsonism Due to Organophosphate Pesticide Intoxication, Five Cases
Neurol 52:1467-1471, Bhatt,M.H.,et al, 1999

Familial Paroxysmal Dystonic Choreoathetosis,Clinical Findings in a Large Japanese Family and Genetic Linkage to 2q
Arch Neurol 56:721-726, Matsuo,H.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

Chronic Subthalamic Nucleus Stimulation Reduces Medication Requirements in Parkinson's Disease
Neurol 53:85-90, Moro,E.,et al, 1999

Transderm-induced Psychosis in Parkinson's Disease
Neurol 53:433-434, Minagar,A.,et al, 1999

Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999

Stereotactic Radiosurgical Pallidotomy and Thalamotomy with the Gamma Knife:MR Imaging Findings with Clinical Correlation-Preliminary Experience
Radiology 212:143-150, Friedman,D.P.,et al, 1999

A 3-Year Randomized Trial of Ropinirole and Bromocriptine in Early Parkinson's Disease
Neurol 53:364-370, Korczyn,A.D.,et al, 1999

Ptosis, Blepharospasm, and Apraxia of Eyelid Opening Secondary to Putaminal Hemorrhage
Neurol 53:652, Verghese,J.,et al, 1999

Zolpidem in Progressive Supranuclear Palsy
NEJM 341:543-544, Daniele,A.,et al, 1999

Comparative Effects of Unilateral and Bilateral Subthalamic Nucleus Deep Brain Stimulation
Neurol 53:561-566, Kumar,R.,et al, 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Globus Pallidus Deep Brain Stimulation for Generalized Dystonia:Clinical and PET Investigation
Neurol 53:871-874, Kumar,R.,et al, 1999

Pathologic Heterogeneity in Clinically Diagnosed Corticobasal Degeneration
Neurol 53:795-800, Boeve,B.F.,et al, 1999

Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999

Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999

Stereotactic Pallidotomy in the Treatment of Parkinson Disease,An Expert Opinion
Arch Neurol 56:1064-1069, Bronstein,J.M.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Progress in Functional Neurosurgery for Parkinson's Disease
Lancet 354:1658-1659,1665, Quinn,N., 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999

Unilateral Pallidotomy for Parkinson's Disease:Results after More Than 1 Year
JNNP 67:511-517, Schrag,A.,et al, 1999

Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999

Localization of a Gene for Myoclonus-Dystonia to Chromosome 7q21-q31
Ann Neurol 46:794-798, Nygaard,T.G.,et al, 1999

Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999

A Case-Controlled MRI/MRA Study of Neurovascular Contact in Hemifacial Spasm
Neurol 53:2132-2139, Ho,S.L.,et al, 1999

Prevalence of Progressive Supranuclear Palsy and Multiple System Atrophy:A Cross-Sectional Study
Lancet 354:1771-1775, Schrag,A.,et al, 1999

Evaluation of Surgery for Parkinson's Disease, A Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 53:1910-1921, Hallett,M.,et al, 1999

Parkinson Disease in Twins,An Etiologic Study
JAMA 281:341-346,376, Tanner,C.M.,et al, 1999

Clinical Correlates of Vascular Parkinsonism
Arch Neurol 56:98-102, Winikates,J.&Jancovic,J., 1999

Mortality Cancer Risk in Parkinsonian Patients:A Population-Based Study
Neurol 52:395-398, Vanacore,N.,et al, 1999

Showing articles 600 to 650 of 1676 << Previous Next >>